Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elite Health SystemsEHSI 37 EV-to-EBITDA is -4.96 as of Aug. 15, 2026. GuruFocus rates EHSI with a GF Score™ of 37/100. The stock has 2 warning signs investors should review. Among 511 Healthcare Providers & Services companies, Elite Health Systems ranks worse than 195694.52% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Elite Health Systems's enterprise value is $23.10 Mil.
Elite Health Systems's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.66 Mil. Therefore, Elite Health Systems's EV-to-EBITDA for today is -4.96.
The historical rank and industry rank for Elite Health Systems's EV-to-EBITDA or its related term are showing as below:
EHSI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -24.77 Med: 0.15 Max: 5.53
Current: -4.96
During the past 13 years, the highest EV-to-EBITDA of Elite Health Systems was 5.53. The lowest was -24.77. And the median was 0.15.
EHSI's EV-to-EBITDA is ranked worse than 100% of 511
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs EHSI: -4.96
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Elite Health Systems (OTCPK:EHSI) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Elite Health Systems's PE Ratio (TTM) for today is calculated as:
Elite Health Systems's share price for today is $0.90.
Elite Health Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.380.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Elite Health Systems's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Elite Health Systems's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elite Health Systems EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Elite Health Systems's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Elite Health Systems's EV-to-EBITDA falls into.
Elite Health Systems's current Enterprise Value is $23.10 Mil.
Elite Health Systems's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elite Health Systems (EHSI) has a EV-to-EBITDA of -4.96 as of Aug. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Elite Health Systems. According to the industry distribution chart, Elite Health Systems ranks #999999 out of 511 companies in the Healthcare Providers & Services industry.
Is Elite Health Systems' EV-to-EBITDA too high?
Elite Health Systems' current EV-to-EBITDA is -4.96. Based on the distribution chart, Elite Health Systems ranks #999999 out of 511 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Elite Health Systems has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Elite Health Systems' EV-to-EBITDA compare to CCEL and PIII?
According to the Healthcare Providers & Services industry distribution chart, Elite Health Systems ranks #999999 out of 511 companies for EV-to-EBITDA. This places Elite Health Systems in the lower half of its industry. The industry median EV-to-EBITDA is 10.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.76, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Elite Health Systems. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elite Health Systems's current EV-to-EBITDA is -4.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elite Health Systems stock overvalued right now?
Elite Health Systems (EHSI) has a current EV-to-EBITDA of -4.96. The current EV-to-EBITDA is -4.96. Elite Health Systems' overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Elite Health Systems (EHSI), the current EV-to-EBITDA is -4.96 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Elite Health Systems Inc is developing Medicare Advantage plans and offering other healthcare-related services with a focus on improving and providing access to healthcare, principally to senior and special needs groups in selected locations. The Company operates through its wholly owned subsidiaries. The company's operating segment includes ESS, which designs, markets, and manages a Medicare Advantage plan or Medicare Part C - a government-approved health plan that delivers Medicare benefits through a managed care or coordinated care model. PSS provides a comprehensive suite of tailored healthcare management solutions to medical practices that enhance operational efficiency, compliance, and patient care.
37GF Score
Get the complete analysis for EHSI
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EHSI has been successfully added to your 
